Price (90d)
$191.82Signal Score (90d)
173Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $3.07B | $908.30M | $6.51 |
| 2024 | $2.88B | $957.50M | $6.74 |
| 2023 | $2.68B | $614.40M | $4.19 |
| 2022 | $2.50B | $954.30M | $6.04 |
| 2021 | $2.46B | $666.30M | $4.12 |
Social Signal Score
Earnings
Wed, Nov 4(in 3 months)
Consensus estimate $1.92 per share
Typical surprise +3.0% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Jul 29$1.98 vs $1.93beat
- Wed, Apr 29$1.82 vs $1.74beat
- Wed, Feb 18$1.82 vs $1.61beat
- Wed, Oct 29$1.72 vs $1.70beat
- Wed, Jul 30$1.88 vs $1.78beat
- Wed, May 7$1.73 vs $1.68beat
Estimates and results for VRSK via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
Project earnings forward and see what return today's price implies.
Seeded from VRSK's reported EPS growth of 12.1% a year over 4 years.
- EPS in 5 years
- $11.56
- Implied price
- $393.17
- Return from $181.67
- 16.7% a year
To earn 15.0% a year on these assumptions you'd need to buy at $195.47 — today's price is already 7.1% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 24 | 29 | 34 | 39 | 44 |
|---|---|---|---|---|---|
| 2.1% | -0.9% | 3.0% | 6.3% | 9.2% | 11.9% |
| 7.1% | 4.0% | 8.0% | 11.5% | 14.6% | 17.4% |
| 12.1% | 8.8% | 13.0% | 16.7% | 19.9% | 22.9% |
| 17.1% | 13.7% | 18.1% | 21.9% | 25.3% | 28.4% |
| 22.1% | 18.6% | 23.1% | 27.1% | 30.6% | 33.8% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (6)
- Newszacks.com·2d ago·Positive
Verisk's AI Expansion Gains Traction as Insurance Adoption Scales VRSK's AI push gains traction as XactAI adoption surges, Core Lines Reimagine expands and subscriptions strengthen recurring revenue.
View source ↗ - Newszacks.com·2d ago·Positive
Is VRSK Worth Buying as Recurring Revenue Battles a Premium Valuation? Verisk pairs strong recurring revenues and cash flow with premium valuation, rising debt costs and expense pressures that warrant investor selectivity.
View source ↗ - Newszacks.com·3d ago·Positive
Here's Why You Should Retain VRSK Stock in Your Portfolio Now Verisk shares gain 12.1% in three months as subscription growth, SaaS demand and strategic investments support its growth outlook.
View source ↗ - News (RSS)investing.com·4d ago·Neutral
Why is Verisk Analytics stock sliding today?
View source ↗ - Newsglobenewswire.com·5d ago·Neutral
Verisk Responds to Delaware Chancery Court Ruling Regarding AccuLynx JERSEY CITY, N.J., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Verisk (Nasdaq: VRSK), a leading data analytics and technology provider to the global insurance industry, today issued the following statement in response to the Delaware Chancery Court ruling regarding AccuLynx:
View source ↗ - Newsreuters.com·7d ago·Negative
Delaware judge orders Verisk to proceed with $2.35 billion AccuLynx deal A Delaware judge ordered data analytics firm Verisk to try completing its planned $2.35 billion acquisition of roofing software maker AccuLynx, with the order coming more than seven months after Verisk said it pulled the plug on the deal.
View source ↗